These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 19300423

  • 1. Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension.
    Zhao WS, Zhai JJ, Wang YH, Xie PS, Yin XJ, Li LX, Cheng KL.
    Am J Hypertens; 2009 Jun; 22(6):680-6. PubMed ID: 19300423
    [Abstract] [Full Text] [Related]

  • 2. Isomer-specific effects of conjugated linoleic acid on blood pressure, adipocyte size and function.
    DeClercq V, Taylor CG, Zahradka P.
    Br J Nutr; 2012 May; 107(10):1413-21. PubMed ID: 21939593
    [Abstract] [Full Text] [Related]

  • 3. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 4. Conjugated linoleic acid prevents the development of essential hypertension in spontaneously hypertensive rats.
    Inoue N, Nagao K, Hirata J, Wang YM, Yanagita T.
    Biochem Biophys Res Commun; 2004 Oct 15; 323(2):679-84. PubMed ID: 15369804
    [Abstract] [Full Text] [Related]

  • 5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 15; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 6. Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components.
    Laso N, Brugué E, Vidal J, Ros E, Arnaiz JA, Carné X, Vidal S, Mas S, Deulofeu R, Lafuente A.
    Br J Nutr; 2007 Oct 15; 98(4):860-7. PubMed ID: 17623486
    [Abstract] [Full Text] [Related]

  • 7. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 15; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 8. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan 15; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 9. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.
    Hermida RC, Ayala DE.
    Hypertension; 2009 Jul 15; 54(1):40-6. PubMed ID: 19433778
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
    Andersen K, Weinberger MH, Egan B, Constance CM, Wright M, Lukashevich V, Keefe DL.
    Cardiovasc Ther; 2010 Dec 15; 28(6):344-9. PubMed ID: 20406241
    [Abstract] [Full Text] [Related]

  • 11. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group.
    J Hypertens; 2008 Jul 15; 26(7):1487-96. PubMed ID: 18551027
    [Abstract] [Full Text] [Related]

  • 12. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK, Lebedev AV, Manoshkina EM, Shamarin VM.
    Ter Arkh; 1998 Jul 15; 70(9):69-71. PubMed ID: 9821232
    [Abstract] [Full Text] [Related]

  • 13. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr 15; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

  • 14. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct 15; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 15. Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue.
    Poirier H, Shapiro JS, Kim RJ, Lazar MA.
    Diabetes; 2006 Jun 15; 55(6):1634-41. PubMed ID: 16731825
    [Abstract] [Full Text] [Related]

  • 16. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.
    Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O.
    Br J Nutr; 2007 Mar 15; 97(3):550-60. PubMed ID: 17313718
    [Abstract] [Full Text] [Related]

  • 17. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
    Syvertsen C, Halse J, Høivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O.
    Int J Obes (Lond); 2007 Jul 15; 31(7):1148-54. PubMed ID: 17031391
    [Abstract] [Full Text] [Related]

  • 18. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
    Ambühl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Sladko K, Roubicek K, Pfister T, Rettenbacher M, Volk HD, Wagner F, Müller P, Jennings GT, Bachmann MF.
    J Hypertens; 2007 Jan 15; 25(1):63-72. PubMed ID: 17143175
    [Abstract] [Full Text] [Related]

  • 19. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct 15; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

  • 20. [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients].
    Belluzzi F, Sernesi L, Centola M, Perlini S.
    Recenti Prog Med; 2009 Nov 15; 100(11):508-11. PubMed ID: 20066882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.